Teneo Adds Two Restructuring Leaders from Carl Marks
Advisory firm Teneo Holdings‘ capital division is expanding its restructuring practice through the addition of several new team members. Teneo Restructuring advises debtors, creditors and key stakeholders in financial restructurings, distressed mergers and acquisitions, and other special situations, both in and out of court.
Christopher K. Wu has joined the firm as president of Teneo Restructuring. In addition, Charles Boguslaski has also joined as a senior managing director. They are joined by Parker Condie, associate. All three will be based in Teneo’s office in New York.
Both Wu and Boguslaski have decades of experience advising boards, management teams, private equity groups, investors and creditors on various aspects of mergers and acquisitions, valuations, corporate finance, reorganizations, insolvency and strategic matters and have worked together successfully for more than a decade.
“We are pleased to welcome Chris, Charles and Parker to our growing team of investment banking professionals,” said Michael Madden, chairman of Teneo Capital. “They bring incredible expertise and experience to the firm, which will provide us with new capabilities we can offer Teneo’s global client base. Restructuring advisory is an important service offering, which is complementary to Teneo’s broad suite of skills.”
Wu most recently served as partner, co-manager of investment banking, and member of the management committee of Carl Marks Advisors, where he worked for 14 years, growing its investment banking practice into a recognized leader in restructuring. Wu has more than 20 years of experience in M&A and restructuring and has advised on more than 100 transactions. He was named Restructuring Banker of the Year in both 2013 and 2014 in the boutique and middle market categories and distressed M&A Banker of the Year in 2016 by Turnaround Atlas Awards. Wu is consistently ranked as a Top 5 Bankruptcy Investment Banker by The Daily Deal. Prior to his tenure at Carl Marks, Wu was a vice president in the global M&A group of J.P. Morgan Securities.
Boguslaski also joins from Carl Marks Advisors where he was most recently a partner and was instrumental in developing its investment banking restructuring platform. He has more than 18 years of investment banking and financial restructuring experience and has been recognized as a leader in the restructuring field. In 2016, he received the Turnaround Atlas Award for Cross Border Distressed M&A Deal of the Year for his sale of Cal Dive International. Prior to Carl Marks, he worked at Gordian Group, a restructuring and M&A investment bank and served in the corporate business development group for Bayer AG where he executed the sale of the Bayer Biological Products division to Cerberus.
Boguslaski also previously held various positions at LECG, a microeconomic consulting firm where he advised on a variety of engagements including mergers, antitrust and competition analyses, financial valuations, business and labor disputes and bankruptcies.
Condie also joins from Carl Marks Advisors, where he was most recently an associate in its investment banking group.